Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
Federal Trade Commission
Cipla
Deloitte
US Department of Justice
QuintilesIMS
McKinsey
Moodys
Daiichi Sankyo
Colorcon

Generated: February 24, 2018

DrugPatentWatch Database Preview

STILBESTROL Drug Profile

« Back to Dashboard

Which patents cover Stilbestrol, and when can generic versions of Stilbestrol launch?

Stilbestrol is a drug marketed by Bristol Myers Squibb and Tablicaps and is included in seven NDAs.

The generic ingredient in STILBESTROL is diethylstilbestrol. There are twenty-six drug master file entries for this compound. Additional details are available on the diethylstilbestrol profile page.
Drug patent expirations by year for STILBESTROL
Medical Subject Heading (MeSH) Categories for STILBESTROL

US Patents and Regulatory Information for STILBESTROL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bristol Myers Squibb STILBESTROL diethylstilbestrol INJECTABLE;INJECTION 004056-003 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Tablicaps STILBESTROL diethylstilbestrol TABLET, DELAYED RELEASE;ORAL 083003-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Bristol Myers Squibb STILBESTROL diethylstilbestrol INJECTABLE;INJECTION 004056-006 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Tablicaps STILBESTROL diethylstilbestrol TABLET;ORAL 083006-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Tablicaps STILBESTROL diethylstilbestrol TABLET, DELAYED RELEASE;ORAL 083005-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Bristol Myers Squibb STILBESTROL diethylstilbestrol INJECTABLE;INJECTION 004056-004 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Bristol Myers Squibb STILBESTROL diethylstilbestrol INJECTABLE;INJECTION 004056-005 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Bristol Myers Squibb STILBESTROL diethylstilbestrol SUPPOSITORY;VAGINAL 004056-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Bristol Myers Squibb STILBESTROL diethylstilbestrol SUPPOSITORY;VAGINAL 004056-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Tablicaps STILBESTROL diethylstilbestrol TABLET;ORAL 083004-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Johnson and Johnson
Accenture
Cantor Fitzgerald
Chinese Patent Office
Deloitte
Boehringer Ingelheim
Express Scripts
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot